Todos Medical announced distribution agreement with Adial Pharma to market Assure/FaStep Covid-19 antibody tests
On Oct. 22, 2020, Todos Medical announced that it had entered into an exclusive supply agreement with U.S….
On Oct. 22, 2020, Todos Medical announced that it had entered into an exclusive supply agreement with U.S….
On Oct. 22, 2020, Gilead Sciences announced that the FDA had approved the antiviral drug Veklury (remdesivir) for…
On Oct. 21, 2020, results from an international, randomized, controlled clinical trial indicated that a four-month daily treatment…
On Oct. 21, 2020, ViiV Healthcare, majority owned by GSK, with Pfizer and Shionogi Limited as shareholders, announced…
On Oct. 21, 2020, ImmunityBio and NantKwest announced that the first patient had been dosed in the Phase…
On Oct. 21, 2020, Purdue Pharma announced that it had entered into an agreement with the U.S. Department…
On Oct. 21, 2020, CerTest Biotec, along with BD (Becton, Dickinson), announced that the VIASURE SARS-CoV-2 (N1 +…
On Oct. 20, 2020, Merck announced findings from two additional Phase 3 studies evaluating the safety, tolerability and…
On Oct. 20, 2020, the NIH announced that the researchers had completed the Adaptive COVID-19 Treatment Trial (ACTT-1),…
On Oct. 20, 2020, PerkinElmer announced that a research team at the National Center for Advancing Translational Sciences…
On Oct. 20, 2020, the U.S. Department of Defense announced an $87 million, seven-year award to the BioIndustrial…
On Oct. 20, 2020, BioMedomics announced that the National Institute for Food and Drug Surveillance (INVIMA) had provided…
On Oct. 20, 2020, BioReference Laboratories, an OPKO Health company, announced that it was accepting specimens for a…
On Oct. 20, 2020, the European Investment Bank (EIB) and Immunic announced the signing of a タ24.5 million…
On Oct. 20, 2020, researchers at Oregon Health & Science University (OHSU) and Oregon State University (OSU) reported…
On Oct. 19, 2020, Alberta Enterprise announced that it had invested an additional $5 million into its third…
On Oct. 19, 2020, researchers annoounced they had discovered that a gene, called PIEZO2, may be responsible for…
On Oct. 19, 2020, Mateon Therapeutics announced the receipt of approval from Republica Argentina Poder Ejecutivo Nacional, the…
On Oct. 19, 2020, Thermo Fisher Scientific announced it had received an expansion of its Emergency Use Authorization…
On Oct. 19, 2020, researchers at MIT, Harvard, and the Broad Institute of MIT announced they had developed…
On Oct. 19, 2020, Bio-Techne announced that ProteinSimple, a Bio-Techne brand, released its SARS-CoV-2 Multi-Antigen Serology Module for…
On Oct. 19, 2020, LabCorp and Swedish, the largest nonprofit healthcare system in the Puget Sound region, announced…
On Oct. 19, 2020, LabCorp announced a test that provided a quantitative measurement of an individualメs SARS-CoV-2 IgG…
On Oct. 19, 2020, ICON announced that it had been re-selected by the Biomedical Advanced Research and Development…
On Oct. 19, 2020, Evotec announced that its Seattle-based subsidiary, Just – Evotec Biologics had received a grant…
On Oct. 19, 2020, Atossa Therapeutics announced it had completed enrollment in its Phase 1 clinical study using…
On Oct. 16, 2020, the NIH launched an adaptive Phase 3 clinical trial to evaluate the safety and…
On Oct. 16, 2020, BD (Becton, Dickinson) announced the CE mark and European availability of a product for…
On Oct. 16, 2020, the U.S. Department of Defense in coordination with the Department of Health and Human…
On Oct. 15, 2020, scientists from the University of Oxford’s Department of Physics announced they had developed an…